Molecular therapies for cancer are reshaping the landscape of oncology, offering promising avenues for targeted treatments that directly interfere with the underlying mechanisms of the disease.Recent breakthroughs highlight the importance of understanding genetic mutations in cancer cells and how they affect critical protein interactions.